# The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)

> **NCT00423579** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 120 (actual)

## Conditions studied

- Hypercholesterolemia
- Coronary Disease

## Interventions

- **DRUG:** Ezetimibe/Simvastatin 10/20 mg
- **DRUG:** simvastatin 40 mg

## Key facts

- **NCT ID:** NCT00423579
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07-01
- **Primary completion:** 2008-03-01
- **Final completion:** 2008-03-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423579, "The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00423579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*